Regulation of thymic regeneration by GPR39
Regulation of thymic regeneration by GPR39
批准号:
10685345
负责人:
Jarrod Dudakov
金额:
$62.32万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-09-01 至 2023-12-31
关键词:
AcuteAgeAgingAgonistAllogenicAntigensApoptosisAutoimmune DiseasesBMP4Biological AvailabilityCell AgingCell CompartmentationCell DeathCell physiologyCellsChronicClinicalCommunicable DiseasesDataDevelopmentDietDietary SupplementationEndothelial CellsExhibitsExposure toG-Protein-Coupled ReceptorsGPR39 geneGenerationsGeneticHematopoieticHematopoietic Stem Cell TransplantationImmuneImmunocompetenceIndividualInfectionInjuryLeadLymphoid CellLymphopeniaMalignant - descriptorMalignant NeoplasmsMediatingMethodsModelingMolecularMorbidity - disease rateMusNatural regenerationNuclear AccidentsOutcomePathway interactionsPatientsPatternPersonsPopulation HeterogeneityProcessProductionProliferatingProteinsPubertyRadiation InjuriesRadiation therapyRegenerative capacityRegenerative pathwayRegenerative responseRegulationRelapseRoleShockSignal TransductionSiteStressStromal CellsT cell reconstitutionT-Cell DevelopmentT-LymphocyteTerrorismTestingTherapeuticThymic epithelial cellThymus GlandTransition ElementsTransplantationZincZinc deficiencyZinc supplementationage relatedagedcancer therapychemotherapycofactorconditioningdrinking waterepithelial repairextracellularfunctional declinegraft vs host diseasehematopoietic cell transplantationimmunogenic cell deathimprovedinnovationinterleukin-22mortalitypreclinical studyregenerativerepairedresponserestorationsevere injurysmall moleculethymic regenerationthymocytetissue regeneration
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
The thymus, which is the primary site of T cell generation, is extremely sensitive to injury; but also has
a remarkable capacity for endogenous repair. However, even though there is continual thymic involution and
regeneration in response to everyday insults like stress and infection, profound thymic damage caused by
common cancer therapies and the conditioning regimes for hematopoietic cell transplantation (HSCT) lead to
prolonged T cell lymphopenia. Furthermore, in the context of allogeneic HCT, the thymus is an extremely
sensitive target to alloreactive T cells during graft versus host disease (GVHD). Consequently, identification of
therapies that can boost T cell reconstitution in recipients of HSCT is a clinical priority.
We have previously identified two distinct pathways of endogenous thymic regeneration, centered on
the production of the regeneration factors IL-22 by innate lymphoid cells (ILCs), and BMP4 by endothelial cells
(ECs); both of which mediate their regenerative effects by targeting thymic epithelial cells (TECs). In our
preliminary data we have shown that Zinc (Zn), which is the second most abundant transition metal in the
body, is critically important for T cell development; with mice fed a Zn-deficient diet exhibiting a profound block
in the differentiation and expansion of thymocytes, which was reversed with dietary supplementation of Zn in
drinking water. Although Zn, which is a co-factor for over 300 proteins and has been implicated in cell
processes such as proliferation and apoptosis, directly influences T cell development at the level of
thymocytes, we found an increase in the levels of extracellular Zn after damage; and that this translocation of
Zn could directly stimulate the damage-associated production of BMP4 by ECs via sensing of Zn by the G-
protein-coupled receptor GPR39.m These studies suggest that under steady-state conditions Zn is used to
promote T cell development, but after damage, Zn released by thymocytes is capable of triggering the
regenerative response by ECs by stimulating GPR39, effectively acting as a damage-associated molecular
pattern (DAMP). Based on our preliminary data, we hypothesize that (a) a switch toward immunogenic cell
death (ICD) in thymocytes after damage leads to the extracellular release of Zn; (b) GPR39-sensing of
released zinc is a master regulator of the endogenous regenerative response to acute damage; and (c)
activation of GPR39 signaling can be exploited into a superior method to promote thymic function and T cell
reconstitution following HSCT. Specifically, our proposal has the following aims: (1) to investigate the ability of
GPR39 signaling to induce multiple distinct pathways of endogenous regeneration after damage; (2) to identify
the role of thymocyte cell death in initiating the production of regenerative factors; and (3) to evaluate if
modulation of GPR39 signaling can be used as a means of improving T cell reconstitution following HSCT.
The studies outlined in this proposal not only have the potential to define important pathways
underlying tissue regeneration but could also result in innovative clinical approaches to enhance thymic
function.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of thymic regeneration by GPR39
-
批准号:10502128
-
项目类别:
-
资助金额:$62.32万
-
财政年份:2022
-
负责人:Jarrod Dudakov
-
依托单位:
Modulation of signaling from damage-associated molecular patterns to improve radiation-induced thymic dysfunction
-
批准号:10667548
-
项目类别:
-
资助金额:$60.64万
-
财政年份:2022
-
负责人:Jarrod Dudakov
-
依托单位:
Modulation of signaling from damage-associated molecular patterns to improve radiation-induced thymic dysfunction
-
批准号:10474884
-
项目类别:
-
资助金额:$59.92万
-
财政年份:2022
-
负责人:Jarrod Dudakov
-
依托单位:
Harnessing endogenous mechanisms of thymic regeneration toboost immune function in recipients of hematopoietic cell transplant
-
批准号:10656565
-
项目类别:
-
资助金额:$57.05万
-
财政年份:2019
-
负责人:Jarrod Dudakov
-
依托单位:
Harnessing endogenous mechanisms of thymic regeneration toboost immune function in recipients of hematopoietic cell transplant
-
批准号:10545013
-
项目类别:
-
资助金额:$40.75万
-
财政年份:2019
-
负责人:Jarrod Dudakov
-
依托单位:
Harnessing endogenous mechanisms of thymic regeneration toboost immune function in recipients of hematopoietic cell transplant
-
批准号:10322998
-
项目类别:
-
资助金额:$16.1万
-
财政年份:2019
-
负责人:Jarrod Dudakov
-
依托单位:
Response of aged thymus to injury and rejuvenation signals
-
批准号:10553993
-
项目类别:
-
资助金额:$63.66万
-
财政年份:2017
-
负责人:Jarrod Dudakov
-
依托单位:
Investigating the role of interleukin-22 in thymus function
-
批准号:9189154
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2016
-
负责人:Jarrod Dudakov
-
依托单位:
Investigating the role of interleukin-22 in thymus function
-
批准号:9268742
-
项目类别:
-
资助金额:$24.71万
-
财政年份:2016
-
负责人:Jarrod Dudakov
-
依托单位:
Investigating the role of interleukin-22 in thymus function
-
批准号:8488026
-
项目类别:
-
资助金额:$17.87万
-
财政年份:2013
-
负责人:Jarrod Dudakov
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: